For the quarter ending 2025-09-30, CPHI had -$357,407 decrease in cash & cash equivalents over the period. -$237,598 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -651,482 | -1,313,939 |
| Depreciation and amortization | 356,034 | 650,176 |
| Credit losses | 25,302 | 709 |
| Inventory write off | 83,947 | 422,932 |
| Trade accounts and other receivables | 117,491 | 185,236 |
| Advances to suppliers | 18,697 | -10,020 |
| Inventories | -57,779 | -321,431 |
| Trade accounts payable | 54,437 | 303,613 |
| Other payables and accrued expenses | -68,702 | 101,678 |
| Advances from customers | 42,835 | -84,899 |
| Prepaid expenses | 178 | -6,773 |
| Net cash used in operating activities | -236,987 | 233,258 |
| Purchases of property and equipment | 611 | 58,259 |
| Advances for intangible assets | 39,987 | 32,627 |
| Net cash used in investing activities | -40,598 | -90,886 |
| Payments of line of credit | -617,961 | 1,092,893 |
| Borrowings and interest from related party | -44,176 | 297,673 |
| Proceeds from lines of credit | - | 695,999 |
| Net cash (used in) provided by financing activities | -122,214 | -99,221 |
| Effect of exchange rate changes on cash | 42,392 | -44,998 |
| Net increase in cash and cash equivalents | -357,407 | -1,847 |
| Cash and cash equivalents at beginning of period | 626,879 | - |
| Cash and cash equivalents at end of period | 267,625 | - |
CHINA PHARMA HOLDINGS, INC. (CPHI)
CHINA PHARMA HOLDINGS, INC. (CPHI)